You might want to look for a better example. Even before prices for HCV drugs went down due to competition, they offered a cure for a life threatening disease

You might want to look for a better example. Even before prices for HCV drugs went down due to competition, they offered a cure for a life threatening disease for less than $100K in the US with minimal side effects, typically in 8 weeks, and with 95% effectiveness. The agent is a small pill taken twice a day. Price is scaled to personal income in country of treatment. That's more like 1/10 of the monetary cost of a transplant, which is a scarce and rationed treatment.